A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy
Clinical trial NCT02993523 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02993523
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-02
- Primary completion
- 2021-12-01
- Enrollment
- 443
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.